These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25026796)

  • 21. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease.
    Muro Y; Sugiura K; Morita Y; Tomita Y
    Lupus; 2008 Mar; 17(3):171-6. PubMed ID: 18372356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [An outline of laboratory tests for autoimmune disorders].
    Misaki Y
    Rinsho Byori; 2003 Feb; Suppl 124():57-65. PubMed ID: 12710033
    [No Abstract]   [Full Text] [Related]  

  • 23. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.
    Op De Beeck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
    Autoimmun Rev; 2011 Oct; 10(12):801-8. PubMed ID: 21741497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The detection of autoantibodies on HEp-2 cells using an indirect immunoperoxidase kit (Colorzyme).
    Fritzler MJ; Wall W; Gohill J; Kinsella TD; Humbel RL
    Diagn Immunol; 1986; 4(4):217-21. PubMed ID: 3530600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunofluorescence].
    Lefèvre S; Lange U
    Z Rheumatol; 2011 Apr; 70(3):228, 230-1. PubMed ID: 21327832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic laboratory tests for systemic autoimmune rheumatic diseases: unmet needs towards harmonization.
    Meroni PL; Borghi MO
    Clin Chem Lab Med; 2018 Sep; 56(10):1743-1748. PubMed ID: 29708880
    [No Abstract]   [Full Text] [Related]  

  • 27. The challenge of identification of autoantibodies specific to systemic autoimmune rheumatic diseases in high throughput operation: proposal of reliable and feasible strategies.
    Pereira KM; Dellavance A; Andrade LE
    Clin Chim Acta; 2014 Nov; 437():203-10. PubMed ID: 25091804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Determination of autoimmune antibodies using Western blot technique in the routine laboratory. Problems with determining and comparing three test kits].
    Bauerfeind S; Heide KG
    Z Rheumatol; 1994; 53(2):66-71. PubMed ID: 8023587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of anti-nuclear antibody by immunofluorescence assay and enzyme immunoassay in childhood systemic lupus erythematosus: experience from Bangladesh.
    Dipti TR; Azam MS; Sattar MH; Rahman SA
    Int J Rheum Dis; 2012 Feb; 15(1):121-5. PubMed ID: 22324956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Methods for determining antinuclear antibodies and their clinical significance].
    Aeschlimann A; Meyer O; Kahn MF; Müller W
    Schweiz Med Wochenschr; 1989 Dec; 119(48):1701-12. PubMed ID: 2694362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests.
    Egerer K; Roggenbuck D; Hiemann R; Weyer MG; Büttner T; Radau B; Krause R; Lehmann B; Feist E; Burmester GR
    Arthritis Res Ther; 2010; 12(2):R40. PubMed ID: 20214808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The value of using HEP/2 cells as compared to sections of rat liver in the detection of autoantibodies using indirect immunofluorescence in human pathology].
    Makni S; Jenhani F; Ayed K
    Rev Rhum Mal Osteoartic; 1989 Oct; 56(10):651-5. PubMed ID: 2512629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of a combined protocol for rational request and utilization of antibody assays improves clinical diagnostic efficacy in autoimmune rheumatic disease.
    Tampoia M; Brescia V; Fontana A; Zucano A; Morrone LF; Pansini N
    Arch Pathol Lab Med; 2007 Jan; 131(1):112-6. PubMed ID: 17227110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Possibilities of immunofluorescence in clinico-immunologic diagnosis].
    Storch W
    Z Gesamte Inn Med; 1983 Feb; 38(4):104-6. PubMed ID: 6344463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing.
    Solomon DH; Kavanaugh AJ; Schur PH;
    Arthritis Rheum; 2002 Aug; 47(4):434-44. PubMed ID: 12209492
    [No Abstract]   [Full Text] [Related]  

  • 36. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
    Sebastian W; Roy A; Kini U; Mullick S
    Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of Western blotting as the confirmatory test for syphilis in patients with rheumatic disease.
    Murphy FT; George R; Kubota K; Fears M; Pope V; Howard RS; Dennis GJ
    J Rheumatol; 1999 Nov; 26(11):2448-53. PubMed ID: 10555908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harmonization of autoimmune diagnostics with antinuclear antibody testing algorithm: approach of appropriateness and clinical relevance.
    Melegari A; Bonaguri C
    Isr Med Assoc J; 2014 Oct; 16(10):640-2. PubMed ID: 25438456
    [No Abstract]   [Full Text] [Related]  

  • 39. European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders.
    Wiik A; Cervera R; Haass M; Kallenberg C; Khamashta M; Meroni PL; Piette JC; Schmitt R; Shoenfeld Y
    Lupus; 2006; 15(7):391-6. PubMed ID: 16898171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rheumatic diseases: current technologies and perspectives of laboratory diagnosis].
    Nasonov EL; Aleksandrova EN
    Ter Arkh; 2010; 82(5):5-9. PubMed ID: 20597263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.